TELA Bio filed the paperwork for a $69 Million IPO on 10/15/2019. The Malvern, PA based company makes interwoven biologic tissue devices used in hernia repair and abdominal wall reconstruction.... read more
TELA Bio filed the paperwork for a $69 Million IPO on 10/15/2019. The Malvern, PA based company makes interwoven biologic tissue devices used in hernia repair and abdominal wall reconstruction.... read more
Frequency Therapeutics updated its $123 Million IPO on 9/23/19. The Woburn, Ma based company is focused on on harnessing the body’s innate biology to repair or reverse damage caused by a broad... read more
IGM updated its IPO filing on 9/17/19. In the amended filing, the Mountain View, CA based biotech said it may raise up to $213 million and offer 10,937,500 shares. IGM will trade on NASDAQ under... read more
CINs are becoming a primary point of engagement for IDNs and are becoming more crucial to population health management and value-based contracts. To this end, CINs are becoming building blocks for... read more
Satsuma Pharmaceuticals file the paperwork for an $80 million IPO on 9/11/19. The company is developing a nasal delivery form of dihydroergotamine mesylate (DHE) for treating migraine headaches.... read more
Azitra, Inc.Appoints Mark Sampson, Ph.D. as Chief Scientific Officer
On 8/27/19, Azitra, Inc., a clinical-stage medical dermatology company addressing severe skin conditions by... read more
Monopar filed an amendment to its IPO filing on 9/10/19. It has raised its upper estimate to $46 Million. The company will trade on NASDAQ under the symbol, “MNPR.” See original... read more
On 9/10/19, Plus Therapeutics filed for a $34 million offering that will consist of Class A units, Class B units, common stock and warrants to purchase common stock. Plus is developing oncology... read more
On 9/6/19 Aprea Therapeutics https://www.aprea.com filed the paperwork for its IPO. The company anticipates raising up to $86 million. Aprea has facilities in... read more
On 9/4/19 Enivsta Holdings updated the filing for its upcoming $738 million IPO. The dental supplies and equipment company spun out of Danaher will be comprised of three operating units: Nobel... read more
On 9/3/19, Turning Point Therapeutics filed the paperwork for a $296 million offering of its common stock. The San Diego based biotech focused on... read more
Pfizer biotech spinout, Springworks Therapeutics, updated it IPO filing on 9/3/19. The company will raise up to $143 million and offer 7,352,941 shares... read more
Finch Therapeutics Raises $53 Million to Advance Microbiome-Based Therapies for Recurrent C. Difficile, Autism and other Disease Areas
Finch Therapeutics Group, Inc., a... read more